285 related articles for article (PubMed ID: 7621254)
21. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
22. Preclinical and clinical experience of antisense therapy for solid tumors.
Webb MS; Zon G
Curr Opin Mol Ther; 1999 Aug; 1(4):458-63. PubMed ID: 11713760
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
[TBL] [Abstract][Full Text] [Related]
24. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
25. EphB4 expression and biological significance in prostate cancer.
Xia G; Kumar SR; Masood R; Zhu S; Reddy R; Krasnoperov V; Quinn DI; Henshall SM; Sutherland RL; Pinski JK; Daneshmand S; Buscarini M; Stein JP; Zhong C; Broek D; Roy-Burman P; Gill PS
Cancer Res; 2005 Jun; 65(11):4623-32. PubMed ID: 15930280
[TBL] [Abstract][Full Text] [Related]
26. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
27. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
[TBL] [Abstract][Full Text] [Related]
28. Papillomaviruses as targets for cancer gene therapy.
Shillitoe EJ; Kamath P; Chen Z
Cancer Gene Ther; 1994 Sep; 1(3):193-204. PubMed ID: 7621251
[TBL] [Abstract][Full Text] [Related]
29. Antisense therapy in malignant diseases: status quo and quo vadis?
Tamm I
Clin Sci (Lond); 2006 Apr; 110(4):427-42. PubMed ID: 16526947
[TBL] [Abstract][Full Text] [Related]
30. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.
Endo S; Zeng Q; Burke NA; He Y; Melhem MF; Watkins SF; Lango MN; Drenning SD; Huang L; Rubin Grandis J
Gene Ther; 2000 Nov; 7(22):1906-14. PubMed ID: 11127578
[TBL] [Abstract][Full Text] [Related]
31. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of E7 antisense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-positive mouse tumor.
He YK; Lui VW; Baar J; Wang L; Shurin M; Almonte C; Watkins SC; Huang L
Gene Ther; 1998 Nov; 5(11):1462-71. PubMed ID: 9930299
[TBL] [Abstract][Full Text] [Related]
35. The NF-kappaB transcription factor in oncogenesis.
Sharma HW; Narayanan R
Anticancer Res; 1996; 16(2):589-96. PubMed ID: 8687102
[TBL] [Abstract][Full Text] [Related]
36. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
37. Specific block of androgen receptor activity by antisense oligonucleotides.
Hamy F; Brondani V; Spoerri R; Rigo S; Stamm C; Klimkait T
Prostate Cancer Prostatic Dis; 2003; 6(1):27-33. PubMed ID: 12664061
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
39. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter.
He Y; Huang L
Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284
[TBL] [Abstract][Full Text] [Related]
40. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides.
Senn C; Hangartner C; Moes S; Guerini D; Hofbauer KG
Eur J Pharmacol; 2005 Oct; 522(1-3):30-7. PubMed ID: 16213482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]